Julie Alison Valenza, PA

Julie Valenza practices at NCH Baker Hospital in Naples, Florida.

Julie Valenza's NPI, 1033100474, was assigned on November 3, 2005. Julie Valenza holds New York license 004363.

Julie Valenza's primary practice is NCH Baker Hospital, at 350 7th N St, Naples, FL 34102 in Collier County. The practice phone is (239) 463-5000.

Julie Valenza's primary practice is NCH Baker Hospital in Naples, Florida. The medical group on file is Collier Medical Specialists. Dmand AI also links Julie Valenza to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Julie Valenza practices. Vendor and product names are available with a free account.

Physician assistant is Julie Valenza's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Julie Valenza is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Julie Valenza is licensed in New York.

Dmand AI lists alzheimer's disease, anxiety, arthritis, asthma, chronic kidney disease, chronic obstructive pulmonary disease (COPD), depression and enlarged prostate among the conditions Julie Valenza treats.

CMS data shows 56 Medicare services from Julie Valenza across 2 procedure codes in 2024, for 55 Medicare patients. Medicare paid $1,438 for them. Every service was in an office.

CMS counts 55 Medicare patients who saw Julie Valenza in 2024. The largest group is 85 and over, with 34 patients. 75% of them have alzheimer's and dementia, and 75% have high blood pressure. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Julie Valenza's median patient age at 78, with 70% women.

In 2024, Julie Valenza wrote 2,794 Medicare Part D claims for 492 patients. 90% of them were for generic drugs. CMS names the drug for 2,295 of them, across 73 drugs with 11 or more claims each, at $73,290 in total drug cost.

CMS Open Payments shows 25 general payments to Julie Valenza from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $173.